$BMRN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOMARIN PHARMACEUTICAL INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in BIOMARIN PHARMACEUTICAL INC. Get notifications about new insider transactions in BIOMARIN PHARMACEUTICAL INC for free.
Page: < prev 1 2 3 4 5 6 7 8 ... 34 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 28 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 4,000 | 57,560 | 292,290 | 288.3 K to 292.3 K (+1.39 %) |
| Feb 22 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 3,000 | 43,170 | 62,000 | |
| Feb 22 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 90.12 | 3,000 | 270,360 | 288,290 | 291.3 K to 288.3 K (-1.03 %) |
| Feb 22 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 3,000 | 43,170 | 291,290 | 288.3 K to 291.3 K (+1.04 %) |
| Feb 15 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 4,000 | 57,560 | 65,000 | |
| Feb 15 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 95.20 | 4,000 | 380,800 | 288,290 | 292.3 K to 288.3 K (-1.37 %) |
| Feb 15 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 4,000 | 57,560 | 292,290 | 288.3 K to 292.3 K (+1.39 %) |
| Feb 07 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 4,000 | 57,560 | 69,000 | |
| Feb 07 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 98.63 | 4,000 | 394,520 | 288,290 | 292.3 K to 288.3 K (-1.37 %) |
| Feb 07 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 4,000 | 57,560 | 292,290 | 288.3 K to 292.3 K (+1.39 %) |
| Jan 24 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 3,000 | 43,170 | 73,000 | |
| Jan 24 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 96.82 | 3,000 | 290,460 | 288,290 | 291.3 K to 288.3 K (-1.03 %) |
| Jan 24 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 3,000 | 43,170 | 291,290 | 288.3 K to 291.3 K (+1.04 %) |
| Jan 15 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 4,000 | 57,560 | 76,000 | |
| Jan 15 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 93.79 | 4,000 | 375,160 | 288,290 | 292.3 K to 288.3 K (-1.37 %) |
| Jan 15 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 4,000 | 57,560 | 292,290 | 288.3 K to 292.3 K (+1.39 %) |
| Jan 11 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 3,000 | 43,170 | 80,000 | |
| Jan 11 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 90.55 | 3,000 | 271,650 | 288,290 | 291.3 K to 288.3 K (-1.03 %) |
| Jan 11 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 3,000 | 43,170 | 291,290 | 288.3 K to 291.3 K (+1.04 %) |
| Jan 10 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 6,000 | 86,340 | 83,000 | |
| Jan 10 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 91.73 | 3,401 | 311,990 | 288,290 | 291.7 K to 288.3 K (-1.17 %) |
| Jan 10 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 91.55 | 1,599 | 146,388 | 291,691 | 293.3 K to 291.7 K (-0.55 %) |
| Jan 10 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 91.14 | 1,000 | 91,144 | 293,290 | 294.3 K to 293.3 K (-0.34 %) |
| Jan 10 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 6,000 | 86,340 | 294,290 | 288.3 K to 294.3 K (+2.08 %) |
| Jan 09 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 3,000 | 43,170 | 89,000 | |
| Jan 09 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 87.58 | 3,000 | 262,740 | 288,290 | 291.3 K to 288.3 K (-1.03 %) |
| Jan 09 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 3,000 | 43,170 | 291,290 | 288.3 K to 291.3 K (+1.04 %) |
| Jan 02 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 3,000 | 43,170 | 92,000 | |
| Jan 02 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 84.04 | 3,000 | 252,120 | 288,290 | 291.3 K to 288.3 K (-1.03 %) |
| Jan 02 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 3,000 | 43,170 | 291,290 | 288.3 K to 291.3 K (+1.04 %) |
| Dec 28 2018 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Option Exercise | M | 14.39 | 2,150 | 30,939 | 2,150 | |
| Dec 28 2018 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Sell | S | 82.53 | 2,150 | 177,440 | 19,160 | 21.3 K to 19.2 K (-10.09 %) |
| Dec 28 2018 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Buy | M | 14.39 | 2,150 | 30,939 | 21,310 | 19.2 K to 21.3 K (+11.22 %) |
| Dec 27 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 4,000 | 57,560 | 95,000 | |
| Dec 27 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 80.50 | 4,000 | 322,000 | 288,290 | 292.3 K to 288.3 K (-1.37 %) |
| Dec 27 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 4,000 | 57,560 | 292,290 | 288.3 K to 292.3 K (+1.39 %) |
| Dec 20 2018 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Grant | A | 68.78 | 175 | 12,037 | 51,245 | 51.1 K to 51.2 K (+0.34 %) |
| Dec 20 2018 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | SVP, Corporate Cont ... | Grant | A | 68.78 | 22 | 1,513 | 12,397 | 12.4 K to 12.4 K (+0.18 %) |
| Dec 18 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.86 | 2,000 | 35,720 | 0 | |
| Dec 18 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 92.64 | 2,000 | 185,280 | 288,290 | 290.3 K to 288.3 K (-0.69 %) |
| Dec 18 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.86 | 2,000 | 35,720 | 290,290 | 288.3 K to 290.3 K (+0.69 %) |
| Dec 18 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Gift | G | 0.00 | 540 | 0 | 181,501 | 182 K to 181.5 K (-0.30 %) |
| Dec 18 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Gift | G | 0.00 | 160 | 0 | 182,041 | 182.2 K to 182 K (-0.09 %) |
| Dec 14 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.86 | 2,000 | 35,720 | 2,000 | |
| Dec 14 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 93.12 | 2,000 | 186,240 | 288,290 | 290.3 K to 288.3 K (-0.69 %) |
| Dec 14 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.86 | 2,000 | 35,720 | 290,290 | 288.3 K to 290.3 K (+0.69 %) |
| Nov 16 2018 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Option Exercise | M | 63.10 | 9,000 | 567,900 | 30,700 | |
| Nov 16 2018 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Sell | S | 94.35 | 600 | 56,611 | 49,135 | 49.7 K to 49.1 K (-1.21 %) |
| Nov 16 2018 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Sell | S | 93.81 | 799 | 74,957 | 49,735 | 50.5 K to 49.7 K (-1.58 %) |
| Nov 16 2018 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Sell | S | 92.21 | 2,400 | 221,297 | 50,534 | 52.9 K to 50.5 K (-4.53 %) |
| Nov 16 2018 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Sell | S | 91.62 | 5,201 | 476,494 | 52,934 | 58.1 K to 52.9 K (-8.95 %) |
| Nov 16 2018 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Buy | M | 63.10 | 9,000 | 567,900 | 58,135 | 49.1 K to 58.1 K (+18.32 %) |
| Nov 05 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.86 | 1,500 | 26,790 | 4,000 | |
| Nov 05 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 97.88 | 1,500 | 146,820 | 288,290 | 289.8 K to 288.3 K (-0.52 %) |
| Nov 05 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.86 | 1,500 | 26,790 | 289,790 | 288.3 K to 289.8 K (+0.52 %) |
| Nov 02 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 4,000 | 57,560 | 99,000 | |
| Nov 02 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 92.55 | 4,000 | 370,200 | 288,290 | 292.3 K to 288.3 K (-1.37 %) |
| Nov 02 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 4,000 | 57,560 | 292,290 | 288.3 K to 292.3 K (+1.39 %) |
| Nov 01 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 1,000 | 14,390 | 103,000 | |
| Nov 01 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 1,000 | 14,390 | 288,290 | 287.3 K to 288.3 K (+0.35 %) |
| Oct 26 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 1,000 | 14,390 | 104,000 | |
| Oct 26 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 1,000 | 14,390 | 287,290 | 286.3 K to 287.3 K (+0.35 %) |
| Oct 05 2018 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Sell | S | 98.98 | 1,000 | 98,985 | 49,135 | 50.1 K to 49.1 K (-1.99 %) |
| Oct 05 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.86 | 1,500 | 26,790 | 5,500 | |
| Oct 05 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 99.36 | 1,500 | 149,040 | 286,290 | 287.8 K to 286.3 K (-0.52 %) |
| Oct 05 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.86 | 1,500 | 26,790 | 287,790 | 286.3 K to 287.8 K (+0.52 %) |
| Sep 28 2018 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Option Exercise | M | 14.39 | 2,150 | 30,939 | 4,300 | |
| Sep 28 2018 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Sell | S | 97.93 | 2,150 | 210,550 | 19,160 | 21.3 K to 19.2 K (-10.09 %) |
| Sep 28 2018 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Buy | M | 14.39 | 2,150 | 30,939 | 21,310 | 19.2 K to 21.3 K (+11.22 %) |
| Sep 27 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 1,000 | 14,390 | 105,000 | |
| Sep 27 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 1,000 | 14,390 | 286,290 | 285.3 K to 286.3 K (+0.35 %) |
| Sep 18 2018 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Sell | S | 99.46 | 616 | 61,265 | 72,734 | 73.4 K to 72.7 K (-0.84 %) |
| Sep 18 2018 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Sell | S | 99.46 | 200 | 19,891 | 73,350 | 73.6 K to 73.4 K (-0.27 %) |
| Sep 18 2018 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Sell | S | 99.45 | 1,400 | 139,230 | 73,550 | 75 K to 73.6 K (-1.87 %) |
| Sep 17 2018 | BMRN | BIOMARIN PHARMACEU ... | MEIER RICHARD A | Director | Option Exercise | M | 21.51 | 12,000 | 258,120 | 0 | |
| Sep 17 2018 | BMRN | BIOMARIN PHARMACEU ... | MEIER RICHARD A | Director | Option Exercise | M | 21.51 | 3,000 | 64,530 | 12,000 | |
| Sep 17 2018 | BMRN | BIOMARIN PHARMACEU ... | MEIER RICHARD A | Director | Sell | S | 99.25 | 200 | 19,850 | 81,610 | 81.8 K to 81.6 K (-0.24 %) |
| Sep 17 2018 | BMRN | BIOMARIN PHARMACEU ... | MEIER RICHARD A | Director | Sell | S | 99.24 | 2,800 | 277,872 | 81,810 | 84.6 K to 81.8 K (-3.31 %) |
| Sep 17 2018 | BMRN | BIOMARIN PHARMACEU ... | MEIER RICHARD A | Director | Buy | M | 21.51 | 3,000 | 64,530 | 84,610 | 81.6 K to 84.6 K (+3.68 %) |
| Sep 17 2018 | BMRN | BIOMARIN PHARMACEU ... | MEIER RICHARD A | Director | Buy | M | 21.51 | 12,000 | 258,120 | 81,610 | 69.6 K to 81.6 K (+17.24 %) |
| Sep 17 2018 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Sell | S | 99.57 | 12,000 | 1,194,840 | 74,950 | 87 K to 75 K (-13.80 %) |
| Sep 07 2018 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 96.94 | 1,000 | 96,935 | 41,685 | 42.7 K to 41.7 K (-2.34 %) |
| Sep 06 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.86 | 1,500 | 26,790 | 7,000 | |
| Sep 06 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 98.16 | 1,500 | 147,240 | 285,290 | 286.8 K to 285.3 K (-0.52 %) |
| Sep 06 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.86 | 1,500 | 26,790 | 286,790 | 285.3 K to 286.8 K (+0.53 %) |
| Aug 30 2018 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Option Exercise | M | 14.39 | 7,500 | 107,925 | 0 | |
| Aug 30 2018 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 99.12 | 200 | 19,824 | 21,160 | 21.4 K to 21.2 K (-0.94 %) |
| Aug 30 2018 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 99.11 | 7,300 | 723,503 | 21,360 | 28.7 K to 21.4 K (-25.47 %) |
| Aug 30 2018 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Buy | M | 14.39 | 7,500 | 107,925 | 28,660 | 21.2 K to 28.7 K (+35.44 %) |
| Aug 29 2018 | BMRN | BIOMARIN PHARMACEU ... | MEIER RICHARD A | Director | Option Exercise | M | 14.39 | 13,000 | 187,070 | 0 | |
| Aug 29 2018 | BMRN | BIOMARIN PHARMACEU ... | MEIER RICHARD A | Director | Option Exercise | M | 14.39 | 2,000 | 28,780 | 13,000 | |
| Aug 29 2018 | BMRN | BIOMARIN PHARMACEU ... | MEIER RICHARD A | Director | Sell | S | 100.12 | 2,000 | 200,235 | 69,610 | 71.6 K to 69.6 K (-2.79 %) |
| Aug 29 2018 | BMRN | BIOMARIN PHARMACEU ... | MEIER RICHARD A | Director | Buy | M | 14.39 | 2,000 | 28,780 | 71,610 | 69.6 K to 71.6 K (+2.87 %) |
| Aug 29 2018 | BMRN | BIOMARIN PHARMACEU ... | MEIER RICHARD A | Director | Buy | M | 14.39 | 13,000 | 187,070 | 69,610 | 56.6 K to 69.6 K (+22.96 %) |
| Aug 28 2018 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Sell | S | 100.00 | 12,500 | 1,250,000 | 130,167 | 142.7 K to 130.2 K (-8.76 %) |
| Aug 28 2018 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Sell | S | 99.00 | 12,500 | 1,237,500 | 142,667 | 155.2 K to 142.7 K (-8.06 %) |
| Aug 22 2018 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 100.09 | 4,200 | 420,365 | 21,160 | 25.4 K to 21.2 K (-16.56 %) |
| Aug 09 2018 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Sell | S | 105.00 | 5,173 | 543,165 | 71,882 | 77.1 K to 71.9 K (-6.71 %) |
| Jul 25 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.86 | 1,500 | 26,790 | 8,500 | |
| Jul 25 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 101.69 | 1,500 | 152,535 | 285,290 | 286.8 K to 285.3 K (-0.52 %) |
| Jul 25 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.86 | 1,500 | 26,790 | 286,790 | 285.3 K to 286.8 K (+0.53 %) |
| Jun 29 2018 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Option Exercise | M | 14.39 | 2,150 | 30,939 | 6,450 | |
| Jun 29 2018 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Sell | S | 93.52 | 2,150 | 201,068 | 19,160 | 21.3 K to 19.2 K (-10.09 %) |
| Jun 29 2018 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Buy | M | 14.39 | 2,150 | 30,939 | 21,310 | 19.2 K to 21.3 K (+11.22 %) |
| Jun 26 2018 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Sell | S | 99.01 | 472 | 46,733 | 51,070 | 51.5 K to 51.1 K (-0.92 %) |
| Jun 26 2018 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Sell | S | 99.00 | 9,528 | 943,272 | 51,542 | 61.1 K to 51.5 K (-15.60 %) |
| Jun 26 2018 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Sell | S | 99.01 | 472 | 46,733 | 51,070 | 51.5 K to 51.1 K (-0.92 %) |
| Jun 26 2018 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Sell | S | 99.00 | 9,528 | 943,272 | 51,542 | 61.1 K to 51.5 K (-15.60 %) |
| Jun 26 2018 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Option Exercise | M | 14.39 | 6,949 | 99,996 | 0 | |
| Jun 26 2018 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Sell | S | 99.01 | 328 | 32,475 | 83,276 | 83.6 K to 83.3 K (-0.39 %) |
| Jun 26 2018 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Option Exercise | M | 14.39 | 6,949 | 99,996 | 0 | |
| Jun 26 2018 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Sell | S | 99.00 | 6,621 | 655,479 | 83,604 | 90.2 K to 83.6 K (-7.34 %) |
| Jun 26 2018 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Sell | S | 99.01 | 328 | 32,475 | 83,276 | 83.6 K to 83.3 K (-0.39 %) |
| Jun 26 2018 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Buy | M | 14.39 | 6,949 | 99,996 | 90,225 | 83.3 K to 90.2 K (+8.34 %) |
| Jun 26 2018 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Sell | S | 99.00 | 6,621 | 655,479 | 83,604 | 90.2 K to 83.6 K (-7.34 %) |
| Jun 26 2018 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Buy | M | 14.39 | 6,949 | 99,996 | 90,225 | 83.3 K to 90.2 K (+8.34 %) |
| Jun 26 2018 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | SVP, Corporate Cont ... | Option Exercise | M | 28.23 | 2,491 | 70,321 | 1,718 | |
| Jun 26 2018 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | SVP, Corporate Cont ... | Option Exercise | M | 28.23 | 2,491 | 70,321 | 1,718 | |
| Jun 26 2018 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | SVP, Corporate Cont ... | Sell | S | 99.50 | 2,491 | 247,855 | 12,375 | 14.9 K to 12.4 K (-16.76 %) |
| Jun 26 2018 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | SVP, Corporate Cont ... | Sell | S | 99.50 | 2,491 | 247,855 | 12,375 | 14.9 K to 12.4 K (-16.76 %) |
| Jun 26 2018 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | SVP, Corporate Cont ... | Buy | M | 28.23 | 2,491 | 70,321 | 14,866 | 12.4 K to 14.9 K (+20.13 %) |
| Jun 26 2018 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | SVP, Corporate Cont ... | Buy | M | 28.23 | 2,491 | 70,321 | 14,866 | 12.4 K to 14.9 K (+20.13 %) |
| Jun 26 2018 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | SVP, Corporate Cont ... | Sell | S | 99.50 | 654 | 65,073 | 12,375 | 13 K to 12.4 K (-5.02 %) |
| Jun 26 2018 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | SVP, Corporate Cont ... | Sell | S | 99.50 | 654 | 65,073 | 12,375 | 13 K to 12.4 K (-5.02 %) |
| Jun 18 2018 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | SVP, Corporate Cont ... | Sell | S | 94.50 | 2,021 | 190,985 | 13,029 | 15.1 K to 13 K (-13.43 %) |
| Jun 18 2018 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Option Exercise | M | 37.46 | 20,681 | 774,710 | 0 | |
| Jun 18 2018 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Option Exercise | M | 26.49 | 1,875 | 49,669 | 0 | |
| Jun 18 2018 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Option Exercise | M | 37.46 | 2,669 | 99,981 | 0 | |
| Jun 18 2018 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Option Exercise | M | 26.49 | 3,775 | 100,000 | 0 | |
| Jun 18 2018 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Option Exercise | M | 21.51 | 2,000 | 43,020 | 0 | |
| Jun 18 2018 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Sell | S | 90.00 | 20,681 | 1,861,375 | 155,167 | 175.8 K to 155.2 K (-11.76 %) |
| Jun 18 2018 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Buy | M | 37.46 | 20,681 | 774,710 | 175,848 | 155.2 K to 175.8 K (+13.33 %) |
| Jun 18 2018 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Sell | S | 90.00 | 1,875 | 168,750 | 155,167 | 157 K to 155.2 K (-1.19 %) |
| Jun 18 2018 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Buy | M | 26.49 | 1,875 | 49,669 | 157,042 | 155.2 K to 157 K (+1.21 %) |
| Jun 18 2018 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Sell | S | 90.00 | 2,669 | 240,210 | 155,167 | 157.8 K to 155.2 K (-1.69 %) |
| Jun 18 2018 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Buy | M | 37.46 | 2,669 | 99,981 | 157,836 | 155.2 K to 157.8 K (+1.72 %) |
| Jun 18 2018 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Sell | S | 90.00 | 3,775 | 339,750 | 155,167 | 158.9 K to 155.2 K (-2.38 %) |
| Jun 18 2018 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Buy | M | 26.49 | 3,775 | 100,000 | 158,942 | 155.2 K to 158.9 K (+2.43 %) |
| Jun 18 2018 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Sell | S | 90.00 | 2,000 | 180,000 | 155,167 | 157.2 K to 155.2 K (-1.27 %) |
| Jun 18 2018 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Buy | M | 21.51 | 2,000 | 43,020 | 157,167 | 155.2 K to 157.2 K (+1.29 %) |
| Jun 14 2018 | BMRN | BIOMARIN PHARMACEU ... | HOMBACH ROBERT J. | Director | Grant | A | 0.00 | 4,300 | 0 | 7,480 | 3.2 K to 7.5 K (+135.22 %) |
| Jun 14 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 1,000 | 14,390 | 106,000 | |
| Jun 14 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 1,000 | 14,390 | 285,290 | 284.3 K to 285.3 K (+0.35 %) |
| Jun 13 2018 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Sell | S | 90.31 | 1,436 | 129,685 | 50,135 | 51.6 K to 50.1 K (-2.78 %) |
| Jun 07 2018 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Grant | A | 0.00 | 4,300 | 0 | 19,160 | 14.9 K to 19.2 K (+28.94 %) |
| Jun 07 2018 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Grant | A | 0.00 | 4,300 | 0 | 42,685 | 38.4 K to 42.7 K (+11.20 %) |
| Jun 07 2018 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Grant | A | 0.00 | 4,300 | 0 | 34,110 | 29.8 K to 34.1 K (+14.42 %) |
| Jun 07 2018 | BMRN | BIOMARIN PHARMACEU ... | Dere Willard H | Director | Grant | A | 0.00 | 4,300 | 0 | 8,990 | 4.7 K to 9 K (+91.68 %) |
| Jun 07 2018 | BMRN | BIOMARIN PHARMACEU ... | Slamon Dennis | Director | Grant | A | 0.00 | 4,300 | 0 | 14,185 | 9.9 K to 14.2 K (+43.50 %) |
| Jun 07 2018 | BMRN | BIOMARIN PHARMACEU ... | PYOTT DAVID E I | Director | Grant | A | 0.00 | 4,300 | 0 | 9,210 | 4.9 K to 9.2 K (+87.58 %) |